The acute event of myocardial infarction (AMI) should be managed with allopathic medicine (oxygen, analgesics, anticoagulants, thrombolytics, nitrates, beta-blockers, digitalis, calcium antagonists, angioplasty and coronary bypass). However, once the emergency has passed, allopathy therapy can be complemented with the objectives of preserving the greatest amount of healthy heart muscle and as prophylaxis to avoid future episodes of AMI. Prophylaxis is important, for which there is an effective biotherapy that is also indicated in the case of manifest myocardial infarction. With continued biotherapy for the usual heart conditions (pre-infarction), infarction can be prevented in a good percentage of cases. Prophylactically, to start (first group), orally (VO), the following drugs are appropriate:
- Strophanthus Complex (symptomatic treatment)
- Cratanodib (symptomatic treatment)
- Cor complex (symptomatic treatment)
- Aesculus (symptomatic treatment)
- Veratrum Album Multipot (in collapse situations)
- Apis Mellifica ( in cases of cardiac edema)
The second group of drugs, twenty-one (21) days after the acute MI, is recommended by PO:
- quelodib
- coen complex
- ubichi complex
- Magnesium (angina pectoris and/or heart rhythm disorders + aging)
- Oligoconstellate (trace elements)
- Apis Mellifica (in cases of cardiac edema)
And 50-60 days post-AMI: functional holodren (VO; Detoxification and drainage) + Quelodib , followed by deep holodren + Quelodib .
And intravenously (IV):